Últimas noticias sobre Noah Holdings (NYSE:NOAH) Bolsa

Noah Holdings

Noah Holdings Ltd is a wealth management service provider. It focuses on wealth investment and asset allocation services for high-net-worth individuals and enterprises in China. The company operates through three segments: wealth management, asset management, and other business. Its product offerings consisting of over-the-counter wealth management and OTC asset management products and mutual fund products. The portfolio of the group mostly includes fixed income products, private equity funds and securities investment funds. Majority of the firm revenue is generated through one-time commissions and recurring service fees paid by third-party product providers.

Noah Holdings Limited American Depositary Shares

Noah Holdings Ltd

NOAH HOLDINGS ADR REP 5 ORD SHS

WIIM

NOAH

Noah Holdings shares are trading higher. The company reported Q2 financial results.

Noah Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOAH#NYSE">NOAH</a>) reported quarterly earnings of $0.21 per share. The company reported $84.744 million in sales this quarter. This is a 34.75 percent decrease over sales of $129.873 million the same period last year.

Earnings

News

Noah Holdings Q2 2024 Adj. EPS $0.21, Sales $84.744M Down From $129.873M YoY

General

Noah Holdings shares are trading higher after the company announced a $50 million share repurchase program.

Noah Holdings Limited ("Noah" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOAH#NYSE">NOAH</a>), a leading and pioneer wealth management service provider offering comprehensive one-stop advisory services on global investment and asset allocation primarily for Mandarin-speaking high-net-worth investors, today announced that as part of its commitment to enhancing shareholder returns, the board of directors of the Company (the "Board") authorized a share repurchase program under which the Company may repurchase up to US$50 million of its American depositary shares or ordinary shares, effective immediately. The authorized term for carrying out this share repurchase program is two years.

Buybacks

Noah Holdings Announces $50M Share Repurchase Program Of Its ADS Or Ordinary Shares, Effective Immediately, Authorized Term For Carrying Out This Share Repurchase Program Is 2-Years

Full Year 2023 Payment of Final and Special Dividend
The Company distributed both a final dividend and a special dividend, each amounting to&nbsp;RMB 509.0 million&nbsp;(approximately&nbsp;US$70.0 million). This translates to a distribution ratio of&nbsp;RMB 1.54&nbsp;(approximately&nbsp;US$0.21&nbsp;or&nbsp;HK$1.65) per share for each dividend, tax inclusive.&nbsp;

Dividends

Noah Holdings' New Policy Results In Record RMB 1,018M Dividend Payout

U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Monday.
Shares of IQVIA Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) rose sharply during Monday's session after the company released better-than-expected second-quarter financial results and <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39885871/iqvia-is-a-solid-investment-with-strong-competitive-positioning-analyst-says-after-">raised its 2024 guidance</a>.
IQVIA reported a second adjusted EPS of $2.64, up from $2.43, beating the consensus of $2.57. Provider of advanced analytics reported sales of $3.81 billion, beating the consensus of $3.79 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
IQVIA Holdings shares jumped 7.4% to $241.07 on Monday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Tellurian Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TELL#NASDAQ">TELL</a>) shares surged 64.5% to $0.9401 after the company announced it will be acquired by Woodside Energy for approximately $900 million.</li>
<li>Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) shares gained 46.6% to $11.08 after Nvidia last week disclosed a stake in the company.</li>
<li>Cassava Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) gained 27.2% to $12.82 after the company announced its first Phase 3 trial is expected to conclude by December and its second Phase 3 trial is expected to conclude by June 2025.</li>
<li>Embecta Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EMBC#NASDAQ">EMBC</a>) climbed 16.4% to $15.34. Embecta is scheduled to host a conference call to discuss its fiscal third quarter 2024 financial results on Friday, Aug. 9.</li>
<li>Terex Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEX#NYSE">TEX</a>) gained 11.2% to $62.76 after the company inked a deal to acquire Environmental Solutions Group (ESG) from Dover Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOV#NYSE">DOV</a>) in a $2.0 billion all-cash transaction.</li>
<li>Aveanna Healthcare Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAH#NASDAQ">AVAH</a>) gained 10.5% to $3.80. Aveanna Healthcare will release its second quarter results before the market open on Thursday, Aug. 8.</li>
<li>Karooooo Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KARO#NASDAQ">KARO</a>) climbed 10.4% to $37.78.</li>
<li>Eliem Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELYM#NASDAQ">ELYM</a>) gained 9.7% to $8.01.</li>
<li>Clearwater Paper Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) rose 9.6% to $53.65 after the company announced a deal to sell its tissue business for $1.06 billion.</li>
<li>SentinelOne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) shares climbed 9.5% to $23.80 after a failed software update from CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) caused global outages.</li>
<li>Summit Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) gained 9% to $9.57.</li>
<li>Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) rose 8.8% to $7.96.</li>
<li>Rentokil Initial plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTO#NYSE">RTO</a>) surged 8% to $31.91 following a report suggesting former BT CEO Philip Jansen is in talks to acquire the company.</li>
<li>Noah Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOAH#NYSE">NOAH</a>) rose 7.7% to $7.78.</li>
<li>TAL Education Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAL#NYSE">TAL</a>) gained 7.4% to $10.84. TAL Education will release its unaudited financial results for the first quarter, before the opening bell on Thursday, Aug. 1.</li>
<li>Reddit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) gained 5.6% to $68.32 after the company announced deals with major sports leagues to get content to its site and draw advertisers.</li>
<li>MINISO Group Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNSO#NYSE">MNSO</a>) gained 5.6% to $18.10.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39881674/top-4-tech-stocks-that-may-explode-in-july">Top 4 Tech Stocks That May Explode In July</a></li>
</ul>

Intraday Update

Markets

Movers

Trading Ideas

AVAH

CRWD

ELYM

EMBC

KARO

MNSO

RDDT

SAVA

SERV

SMMT

TELL

IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday

U.S. stock futures were lower this morning, with the Nasdaq futures falling around 0.2% on Wednesday.
Shares of Simulations Plus, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLP#NASDAQ">SLP</a>) fell sharply in today's pre-market trading after the company reported third-quarter financial results and issued FY24 EPS guidance below estimates. Also, the company announced that it will discontinue its <a href="https://www.benzinga.com/quote/SLP/earnings">quarterly cash dividend</a>.
Simulations Plus shares declined 5.3% to $44.39 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>First Foundation Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFWM#NASDAQ">FFWM</a>) shares tumbled 27.7% to $4.75 in pre-market trading after the company announced that affiliates of Fortress Investment Group, Canyon Partners, Strategic Value Bank Partners, and North Reef Capital have agreed to make individual investments aggregating to $228 million in the company.</li>
<li>Repay Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPAY#NASDAQ">RPAY</a>) shares slipped 14.1% to $8.78 in pre-market trading after the company announced pricing of its convertible notes offering.</li>
<li>Noah Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOAH#NYSE">NOAH</a>) shares declined 10.7% to $9.20 in pre-market trading after gaining over 5% on Tuesday.</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) shares fell 5.5% to $24.51 in pre-market trading. NANO Nuclear Energy recently announced that it has signed a MoU to collaborate with Curio Solutions to optimize Curio&#8217;s nuclear fuel recycling capabilities for next-generation portable nuclear microreactors.</li>
<li>American Software, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSWA#NASDAQ">AMSWA</a>) shares fell 5% to $8.62 in pre-market trading.</li>
<li>Garrett Motion Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTX#NASDAQ">GTX</a>) shares declined 4.5% to $8.30 in pre-market trading.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/markets/equities/24/07/39594936/how-to-earn-500-a-month-from-greenbrier-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Greenbrier Stock Ahead Of Q3 Earnings</a>
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>

Pre-Market Outlook

AMSWA

FFWM

RPAY

Simulations Plus Posts Q3 Results, Joins First Foundation And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Shares of American Eagle Outfitters, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) fell during Thursday's session <a href="https://www.benzinga.com/news/earnings/24/05/39074813/american-eagle-outfitters-reports-q1-results-the-details">following first-quarter results</a>.
American Eagle Outfitters reported adjusted earnings of 17 cents per share and quarterly revenue of $1.143 billion, up from $1.08 billion from the same period last year, but below the analyst estimate of $1.15 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
American Eagle Outfitters sees second-quarter operating income in a range of $95 million to $100 million and fiscal-year 2024 operating income in a range of $445 million and $465 million.
American Eagle Outfitters shares fell 4.5% to $22.98 on Thursday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Cue Health Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLTH#NASDAQ">HLTH</a>) shares jumped 100.7% to $0.11. Cue Health shares dipped around 40% on Wednesday after the company announced that it filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code in the District of Delaware to pursue a wind down of its business.</li>
<li>Smart for Life, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMFL#NASDAQ">SMFL</a>) shares jumped 57% to $6.14 after gaining around 17% on Wednesday. Smart For Life completed restructuring program, enhancing financial stability.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) rose 51% to $0.6735. Faraday Future Intelligent Electric recently reported worse-than-expected fiscal year 2023 sales results and withdrew its production target guidance. The company also received a written notice from Nasdaq regarding its failure to timely file the Quarterly Report on Form 10-Q, further impacting investor confidence.</li>
<li>Latam Logistic Properties, S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPA#NYSE">LPA</a>) gained 61% to $53.35.</li>
<li>OneMedNet Corporation. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) shares climbed 41.5% to $2.7650 after the company announced that it has entered into a non-exclusive three-year Master Services Agreement with an undisclosed U.S.-based medical technology company.</li>
<li>Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) gained 33% to $3.6931</li>
<li>Kintara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTRA#NASDAQ">KTRA</a>) shares rose 26% to $0.3421 after jumping around 45% on Wednesday.&nbsp;</li>
<li>Phoenix New Media Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FENG#NYSE">FENG</a>) jumped 26% to $2.2781.</li>
<li>Foot Locker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) gained 25.9% to $28.35 following a first-quarter earnings beat.</li>
<li>American Superconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSC#NASDAQ">AMSC</a>) shares jumped 25.4% to $19.79 following strong quarterly earnings.</li>
<li>Red Robin Gourmet Burgers, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRGB#NASDAQ">RRGB</a>) jumped 22% to $8.21 following first-quarter results.</li>
<li>SOBR Safe, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) gained 21.8% to $0.3682.</li>
<li>Burlington Stores, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) rose 19.2% to $238.93 following better-than-expected first-quarter earnings.</li>
<li>Petco Health and Wellness Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) gained 18.4% to $3.7088.</li>
<li>Claros Mortgage Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMTG#NYSE">CMTG</a>) rose 16.1% to $8.11.</li>
<li>Humacyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUMA#NASDAQ">HUMA</a>) climbed 16% to $8.95.</li>
<li>Fitell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) climbed 15.1% to $19.57.</li>
<li>Nexalin Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXL#NASDAQ">NXL</a>) shares climbed 15% to $0.7650 after dipping 29% on Wednesday.</li>
<li>Alignment Healthcare, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALHC#NASDAQ">ALHC</a>) gained 12.6% to $7.86 after Baird initiated coverage on the stock with an Outperform rating and $10 price target.</li>
<li>HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) rose 12.5% to $36.94 following better-than-expected second-quarter financial results.</li>
<li>C3.ai, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>) gained 12.2% to $26.89 following strong fourth-quarter earnings.</li>
<li>Credo Technology Group Holding Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) gained 12.5% to $22.76 following upbeat earnings.</li>
<li>Forward Air Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRD#NASDAQ">FWRD</a>) gained 11.5% to $15.98</li>
<li>Birkenstock Holding plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIRK#NYSE">BIRK</a>) rose 10.5% to $55.26 after the company reported strong second-quarter earnings and raised its full-year revenue growth guidance.</li>
<li>Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) gained 9% to $78.37 following first-quarter earnings.</li>
<li>Advance Auto Parts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) rose 5.4% to $65.88.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Maxeon Solar Technologies, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAXN#NASDAQ">MAXN</a>) shares fell 38% to $1.9276 after the company reported worse-than-expected first-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Webuy Global Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBUY#NASDAQ">WBUY</a>) dipped 35% to $0.49</li>
<li>UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) fell 34.8% to $11.94 after the company reported first-quarter earnings, issued weak revenue guidance and announced a CEO transition. Some analysts downgraded the stock following the report.</li>
<li>NovaBay Pharmaceuticals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBY#NYSE">NBY</a>) fell 30.7% to $0.1130. NovaBay Pharmaceuticals announced plans for a 1-for-35 reverse stock split and revealed the receipt of NYSE American notice regarding stockholders' equity.</li>
<li>flyExclusive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYX#NASDAQ">FLYX</a>) dipped 29.4% to $5.76.</li>
<li>Kohl&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) declined 27% to $19.89 following worse-than-expected quarterly financial results.</li>
<li>Tungray Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRSG#NASDAQ">TRSG</a>) fell 23.7% to $2.86.</li>
<li>Salesforce, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) shares fell 20.1% to $216.95. Salesforce reported upbeat earnings for the first quarter, while sales missed estimates. The company issued weak guidance for the second quarter.</li>
<li>Noah Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOAH#NYSE">NOAH</a>) declined 19.4% to $10.88 after the company reported first-quarter earnings. JP Morgan downgraded the stock from Overweight to Neutral and lowered its price target from $18 to $13.</li>
<li>Sonoma Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNOA#NASDAQ">SNOA</a>) shares fell 18.1% to $0.2124 after gaining over 28% on Wednesday.</li>
<li>Nutanix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) fell 17.7% to $60.33 after reporting quarterly earnings.</li>
<li>Hywin Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYW#NASDAQ">HYW</a>) dipped 17.6% to $0.3461. Hywin Holdings announced receipt of notification from the Nasdaq.</li>
<li>Brand Engagement Network, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) shares fell 17.2% to $2.1819. BEN shares surged around 108% on Wednesday after the company announced a $4.95 million private placement and appointed Paul Chang to Co-CEO.</li>
<li>Build-A-Bear Workshop, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBW#NYSE">BBW</a>) declined 14.1% to $27.49 following worse-than-expected first-quarter financial results.</li>
<li>LightInTheBox Holding Co., Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LITB#NYSE">LITB</a>) fell 12% to $0.55.</li>
<li>Confluent, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) declined 7.2% to $28.08.</li>
<li>GitLab Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) fell 7% to $49.43.</li>
<li>Abercrombie &amp; Fitch Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) declined 6.5% to $177.11. Abercrombie &amp; Fitch posted better-than-expected first-quarter financial results and raised guidance on Wednesday.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/top-stories/24/05/39088775/nvidia-ge-healthcare-technologies-and-a-video-streaming-giant-on-cnbcs-final-trades">Nvidia, GE HealthCare Technologies And A Video Streaming Giant On CNBC&#8217;s &#8216;Final Trades</a>&#8216;

ALHC

AMSC

BIRK

BNAI

BURL

CFLT

CMTG

CRDO

FENG

FFIE

FLYX

FTEL

FWRD

GTLB

HLTH

HUMA

Kintara Therapeutics, Inc. - Common Stock

KTRA

LITB

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

NTNX

ONMD

PATH

RRGB

SMFL

SNOA

SOBR

TRSG

WBUY

WOOF

Why American Eagle Outfitters Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Noah Holdings shares are trading lower after the company reported Q1 earnings. JP Morgan downgraded the stock from Overweight to Neutral and lowered its price target from $18 to $13.

JP Morgan analyst Katherine Lei downgrades Noah Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOAH#NYSE">NOAH</a>) from Overweight to Neutral and lowers the price target from $18 to $13.

Downgrades

Price Target

Analyst Ratings

JP Morgan Downgrades Noah Holdings to Neutral, Lowers Price Target to $13

Noah Holdings Q1 EPADS $0.32, Sales $89.960M Down From $117.838M YoY

Shares of LuxUrban Hotels Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/luxh#NASDAQ">LUXH</a>) fell sharply during Wednesday&rsquo;s session after the company issued preliminary fourth-quarter <a href="https://www.benzinga.com/quote/LUXH/earnings">revenue outlook below estimates</a>.
LuxUrban said it expects preliminary revenue of $28.2 million for the fourth quarter, versus market estimates of $34.199 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
LuxUrban Hotels shares dipped 27.4% to $1.5523 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>MariaDB plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mrdb#NYSE">MRDB</a>) climbed 70.4% to $0.3850 after Progress Software announced that it is possibly considering an offer for the company.</li>
<li>Lixte Biotechnology Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lixt#NASDAQ">LIXT</a>) shares jumped 68.6% to $3.8099 after the company announced the publication of pre-clinical data on its lead clinical compound, LB-100.</li>
<li>Nutriband Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntrb#NASDAQ">NTRB</a>) gained 33.2% to $3.9950 after the company provided a clinical and regulatory path overview for its AVERSA Fentanyl patch.</li>
<li>Verb Technology Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/verb#NASDAQ">VERB</a>) surged 30.5% to $0.3656 after the company announced that its MARKET.live entered into a formal partnership with TikTok to become a service provider for TikTok Shop and will receive a TikTok Shop Partner designation.</li>
<li>PaySign, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pays#NASDAQ">PAYS</a>) gained 28.2% to $4.3299 after the company announced better-than-expected fourth-quarter results.</li>
<li>Destiny Tech100 Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dxyz#NASDAQ">DXYZ</a>) rose 26.6% to $11.39 after gaining 9% on Tuesday.</li>
<li>PAVmed Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pavm#NASDAQ">PAVM</a>) gained 19.7% to $2.4798 after the company issued business update and fourth quarter financial results.</li>
<li>Noah Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/noah#NYSE">NOAH</a>) rose 17.5% to $11.89 after the company reported fourth quarter financial results.</li>
<li>NuScale Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smr#NYSE">SMR</a>) rose 17.5% to $4.89.</li>
<li>The ONE Group Hospitality, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stks#NASDAQ">STKS</a>) shares rose 17.2% to $4.70 after the company announced that it will acquire Safflower Holdings.</li>
<li>Trump Media &amp; Technology Group Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/djt#NASDAQ">DJT</a>) gained 16.7% to $67.68 after jumping 16% on Tuesday.</li>
<li>Ouster, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/oust#NYSE">OUST</a>) gained 16.7% to $5.82 following strong quarterly sales.</li>
<li>Ontrak, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/otrk#NASDAQ">OTRK</a>) rose 16.3% to $0.4931.</li>
<li>Cazoo Group Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/czoo#NYSE">CZOO</a>) rose 15.5% to $7.22.</li>
<li>A2Z Smart Technologies Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/az#NASDAQ">AZ</a>) surged 15.3% to $0.5301.</li>
<li>nCino, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncno#NASDAQ">NCNO</a>) gained 15.2% to $34.78 as the company reported better-than-expected fourth-quarter results and issued FY25 adjusted earnings guidance above estimates..</li>
<li>Lexicon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxrx#NASDAQ">LXRX</a>) climbed 11.6% to $2.22.</li>
<li>Nuvation Bio Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nuvb#NASDAQ">NUVB</a>) shares rose 10% to $3.1688. Nuvation Bio shares gained 28% on Tuesday after BTIG upgraded the stock from Neutral to Buy.</li>
<li>Cintas Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctas#NASDAQ">CTAS</a>) gained 9.7% to $694.62 after the company reported better-than-expected third-quarter financial results and raised FY24 guidance.</li>
<li>Semtech Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smtc#NASDAQ">SMTC</a>) rose 7.8% to $27.12.</li>
<li>Marvell Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrvl#NASDAQ">MRVL</a>) gained 5.6% to $72.04.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Gamida Cell Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmda#NASDAQ">GMDA</a>) shares fell 83.2% to $0.0575 after the company reported fourth-quarter results and disclosed the commencement of a restructuring process.</li>
<li>Direct Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drct#NASDAQ">DRCT</a>) dipped 44.8% to $14.60 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Velo3D, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vld#NYSE">VLD</a>) fell 41.2% to $0.3401 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Ryvyl Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvyl#NASDAQ">RVYL</a>) dipped 37.8% to $2.46 following fourth-quarter results.</li>
<li>Forge Global Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/frge#NYSE">FRGE</a>) fell 26.1% to $1.96 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Organigram Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ogi#NASDAQ">OGI</a>) dipped 22% to $2.08 as the company announced pricing of overnight marketed public offering.</li>
<li>Akili, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akli#NASDAQ">AKLI</a>) shares tumbled 21.2% to $0.3002. The company received a notice of allowance for U.S. Patent Application 17/890,478 titled Cognitive Platform For Deriving Effort Metric For Optimizing Cognitive Treatment (Using Data Computed With Artificial Neural Network Or Deep Learning Techniques).</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) shares fell 19.4% to $3.17. Mesoblast shares jumped over 78% on Tuesday after the FDA informed the company that the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission of the proposed Biologics License Application for remestemcel-L for treatment of pediatric patients with steroid-refractory acute graft versus host disease.</li>
<li>X Financial (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xyf#NYSE">XYF</a>) fell 19.2% to $3.7250 following fourth-quarter results.</li>
<li>JOANN Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/joan#NASDAQ">JOAN</a>) fell 18.2% to $0.09 after dipping over 6% on Tuesday. The Nasdaq recently determined that the company is no longer suitable for listing and its stock will be suspended on March 28.</li>
<li>Bit Origin Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btog#NASDAQ">BTOG</a>) fell 18.1% to $4.31.</li>
<li>C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) fell 17.4% to $0.0397. C3is recently reported a year-over-year increase in fourth-quarter financial results.</li>
<li>AEye, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lidr#NASDAQ">LIDR</a>) declined 14.6% to $1.34 after the company reported worse-than-expected fourth-quarter revenue results.</li>
<li>GameStop Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gme#NYSE">GME</a>) shares fell 14.4% to $13.27 as the company posted weaker-than-expected results for its fourth quarter on Tuesday.</li>
<li>Sonida Senior Living, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snda#NYSE">SNDA</a>) fell 14% to $27.78 following fourth-quarter results.</li>
<li>Nocera, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncra#NASDAQ">NCRA</a>) dipped 13.5% to $1.15.</li>
<li>Bowman Consulting Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bwmn#NASDAQ">BWMN</a>) fell 11.4% to $34.99 after the company priced a $45 million public offering of common stock at $34 per share.</li>
<li>Reddit, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rddt#NYSE">RDDT</a>) fell 11.3% to $ 57.75.</li>
<li>Krispy Kreme, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dnut#NASDAQ">DNUT</a>) fell 10.4% to $15.54.</li>
<li>Abits Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abts#NASDAQ">ABTS</a>) fell 10.3% to $0.7001 after gaining 7% on Tuesday.</li>
<li>Astera Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alab#NASDAQ">ALAB</a>) fell 8.8% to $75.99 amid post-IPO volatility.</li>
<li>XPeng Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpev#NYSE">XPEV</a>) declined 8.4% to $7.82.</li>
<li>Liquidia Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lqda#NASDAQ">LQDA</a>) fell 7% to $14.81.</li>
<li>NIO Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) fell 5.9% to $4.4959 after the company cut its first-quarter delivery outlook.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/03/37956326/netflix-to-rally-over-15-here-are-10-top-analyst-forecasts-for-wednesday"> Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday </a>

Penny Stocks

Small Cap

ABTS

AKLI

ALAB

BTOG

BWMN

CISS

CTAS

CZOO

DNUT

DRCT

DXYZ

FRGE

GMDA

JOAN

LIDR

LIXT

LQDA

LUXH

LXRX

MESO

MRDB

MRVL

NCNO

NCRA

NTRB

NUVB

OTRK

OUST

PAVM

PAYS

RVYL

SMTC

SNDA

STKS

VERB

XPEV

Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.
Shares of Cintas Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctas#NASDAQ">CTAS</a>) rose sharply during Wednesday&rsquo;s session after the company reported better-than-expected third-quarter financial results and <a href="https://www.benzinga.com/quote/CTAS/earnings">raised FY24 guidance</a>.
Cintas posted GAAP earnings of $3.84 per share, beating market estimates of $3.59 per share. The company&rsquo;s quarterly sales came in at $2.406 billion, versus expectations of $2.386 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Cintas shares climbed 9.7% to $694.62 on Wednesday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>PaySign, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pays#NASDAQ">PAYS</a>) shares jumped 28.2% to $4.3299 after the company announced better-than-expected fourth-quarter results.</li>
<li>Noah Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/noah#NYSE">NOAH</a>) climbed 17.5% to $11.89 after the company reported fourth quarter financial results.</li>
<li>NuScale Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smr#NYSE">SMR</a>) gained 17.5% to $4.89.</li>
<li>The ONE Group Hospitality, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stks#NASDAQ">STKS</a>) shares climbed 17.2% to $4.70 after the company announced that it will acquire Safflower Holdings.</li>
<li>Trump Media &amp; Technology Group Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/djt#NASDAQ">DJT</a>) climbed 16.7% to $67.68 after jumping 16% on Tuesday.</li>
<li>nCino, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncno#NASDAQ">NCNO</a>) rose 15.2% to $34.78 as the company reported better-than-expected fourth-quarter results and issued FY25 adjusted earnings guidance above estimates..</li>
<li>Lexicon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxrx#NASDAQ">LXRX</a>) gained 11.6% to $2.22.</li>
<li>Nuvation Bio Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nuvb#NYSE">NUVB</a>) rose 11.3% to $3.2050 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $1.40 to $10.</li>
<li>Annexon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/annx#NASDAQ">ANNX</a>) gained 10.6% to $7.61 following quarterly results.</li>
<li>NovoCure Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvcr#NASDAQ">NVCR</a>) gained 8.6% to $14.19 after the company&#39;s METIS Phase 3 trial met primary endpoint, demonstrating statistically significant extension in time to intracranial progression for brain metastases from non-small cell lung cancer.</li>
<li>Akebia Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akba#NASDAQ">AKBA</a>) gained 8% to $2.16.</li>
<li>Semtech Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smtc#NASDAQ">SMTC</a>) shares gained 7.8% to $27.12.</li>
<li>Marvell Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrvl#NASDAQ">MRVL</a>) rose 5.6% to $72.04.</li>
<li>The E.W. Scripps Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssp#NASDAQ">SSP</a>) gained 5.6% to $3.8650.</li>
<li>Wayfair Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/w#NYSE">W</a>) rose 5.4% to $68.27.</li>
<li>Merck &amp; Co., Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mrk#NYSE">MRK</a>) gained 4.4% to $131.09 after the company received FDA approval for Winrevair (sotatercept) for adults with pulmonary arterial hypertension.</li>
<li>Kohl&#39;s Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kss#NYSE">KSS</a>) rose 4.1% to $27.36.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37956686/top-3-consumer-stocks-that-may-rocket-higher-this-quarter"> Top 3 Consumer Stocks That May Rocket Higher This Quarter</a>

AKBA

ANNX

NVCR

Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday

Noah shares are trading higher after the company reported Q4 financial results.

Noah Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOAH#NYSE">NOAH</a>) reported quarterly earnings of $0.47 per share. This is a 51.61 percent increase over earnings of $0.31 per share from the same period last year. The company reported $112.61 million in sales this quarter. This is a 11.95 percent decrease over sales of $127.89 million the same period last year.

Noah Holdings Q4 Adj EPS $0.47 Up From $0.31 YoY, Sales $112.61M Down From $127.89M YoY

<h3>Companies Reporting Before The Bell</h3>
&bull; bluebird bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLUE#NASDAQ">BLUE</a>) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
&bull; AIM ImmunoTech (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AIM#AMEX">AIM</a>) is estimated to report earnings for its fourth quarter.
&bull; Elbit Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESLT#NASDAQ">ESLT</a>) is projected to report quarterly earnings at $1.38 per share on revenue of $1.52 billion.
&bull; GDS Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) is likely to report quarterly loss at $0.33 per share on revenue of $357.63 million.
&bull; Bragg Gaming Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRAG#NASDAQ">BRAG</a>) is estimated to report quarterly loss at $0.01 per share on revenue of $37.82 million.
&bull; BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) is expected to report earnings for its fourth quarter.
&bull; Zhihu (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZH#NYSE">ZH</a>) is likely to report quarterly loss at $0.04 per share on revenue of $148.11 million.
&bull; DouYu Intl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOYU#NASDAQ">DOYU</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $170.91 million.
&bull; Waterdrop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WDH#NYSE">WDH</a>) is estimated to report quarterly earnings at $0.01 per share on revenue of $94.55 million.
&bull; Forza X1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRZA#NASDAQ">FRZA</a>) is likely to report earnings for its fourth quarter.
&bull; Acumen Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABOS#NASDAQ">ABOS</a>) is likely to report earnings for its fourth quarter.
&bull; Twin Vee PowerCats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEEE#NASDAQ">VEEE</a>) is likely to report earnings for its fourth quarter.
&bull; Delcath Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCTH#NASDAQ">DCTH</a>) is expected to report quarterly loss at $0.51 per share on revenue of $540 thousand.
&bull; Volato Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SOAR#AMEX">SOAR</a>) is estimated to report earnings for its fourth quarter.
&bull; Movado Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) is likely to report quarterly earnings at $0.39 per share on revenue of $174.80 million.
&bull; Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) is estimated to report earnings for its fourth quarter.
&bull; McCormick &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) is expected to report quarterly earnings at $0.58 per share on revenue of $1.56 billion.
&bull; Kaspi.kz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSPI#NASDAQ">KSPI</a>) is estimated to report earnings for its first quarter.
&bull; TD Synnex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) is likely to report quarterly earnings at $2.84 per share on revenue of $14.36 billion.
<h3>Companies Reporting After The Bell</h3>
&bull; Sidus Space (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) is estimated to report earnings for its fourth quarter.
&bull; Marpai (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRAI#NASDAQ">MRAI</a>) is estimated to report earnings for its fourth quarter.
&bull; NovaBay Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NBY#AMEX">NBY</a>) is likely to report quarterly loss at $0.30 per share on revenue of $3.40 million.
&bull; Aptose Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APTO#NASDAQ">APTO</a>) is projected to report earnings for its fourth quarter.
&bull; Direct Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) is likely to report quarterly earnings at $0.26 per share on revenue of $65.95 million.
&bull; US Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USEG#NASDAQ">USEG</a>) is expected to report quarterly loss at $0.03 per share on revenue of $8.87 million.
&bull; X Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYF#NYSE">XYF</a>) is likely to report earnings for its fourth quarter.
&bull; Iridex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRIX#NASDAQ">IRIX</a>) is likely to report quarterly loss at $0.05 per share on revenue of $14.90 million.
&bull; iPath Series B Carbon Exchange-Traded Notes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRN#NYSE">GRN</a>) is projected to report quarterly loss at $0.01 per share on revenue of $13.40 million.
&bull; Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) is likely to report quarterly loss at $0.11 per share on revenue of $1.64 million.
&bull; BioAtla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAB#NASDAQ">BCAB</a>) is expected to report earnings for its fourth quarter.
&bull; GameStop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) is likely to report quarterly earnings at $0.29 per share on revenue of $2.05 billion.
&bull; Forge Global Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRGE#NYSE">FRGE</a>) is likely to report quarterly loss at $0.10 per share on revenue of $19.57 million.
&bull; Biora Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOR#NASDAQ">BIOR</a>) is expected to report earnings for its fourth quarter.
&bull; ProSomnus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSA#NASDAQ">OSA</a>) is expected to report quarterly loss at $0.31 per share on revenue of $7.37 million.
&bull; ATA Creativity Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AACG#NASDAQ">AACG</a>) is likely to report earnings for its fourth quarter.
&bull; Noah Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOAH#NYSE">NOAH</a>) is estimated to report earnings for its fourth quarter.
&bull; PAVmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAVM#NASDAQ">PAVM</a>) is projected to report quarterly loss at $1.89 per share on revenue of $1.05 million.
&bull; AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) is likely to report quarterly loss at $1.20 per share on revenue of $100 thousand.
&bull; Velo3D (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLD#NYSE">VLD</a>) is likely to report quarterly loss at $0.08 per share on revenue of $19.50 million.
&bull; Progress Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRGS#NASDAQ">PRGS</a>) is expected to report quarterly earnings at $1.14 per share on revenue of $181.91 million.
&bull; WidePoint (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/WYY#AMEX">WYY</a>) is estimated to report earnings for its fourth quarter.
&bull; LuxUrban Hotels (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUXH#NASDAQ">LUXH</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $34.20 million.
&bull; Oxbridge Re Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXBR#NASDAQ">OXBR</a>) is expected to report earnings for its fourth quarter.
&bull; Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) is estimated to report quarterly earnings at $2.58 per share on revenue of $2.38 billion.
&bull; Ouster (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) is likely to report quarterly loss at $0.83 per share on revenue of $24.06 million.
&bull; Ncino (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) is expected to report quarterly earnings at $0.12 per share on revenue of $124.62 million.
&bull; PaySign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYS#NASDAQ">PAYS</a>) is projected to report quarterly earnings at $0.02 per share on revenue of $12.62 million.
&bull; Ryvyl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVYL#NASDAQ">RVYL</a>) is estimated to report quarterly loss at $0.40 per share on revenue of $18.00 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

AACG

ABOS

APTO

BCAB

BIOR

BLRX

BLUE

BRAG

CGTX

CNXC

DCTH

DOYU

ESLT

FRZA

INTZ

IRIX

KSPI

MRAI

OXBR

PRGS

SIDU

SOAR

USEG

VEEE

Earnings Scheduled For March 26, 2024

Noah Holdings Provides Updates On The Status Of The Legal Proceedings Related To Certain Credit Funds Managed By Shanghai Gopher Asset Management

Chinese financial services provider&nbsp;Noah Holdings Limited&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/noah#NYSE">NOAH</a>) said its Board of Directors has approved a separation of&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/23/12/n36423771/noah-announces-change-of-chief-executive-officer" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">the chief executive officer and chairperson roles</a>.
Zhe Yin, co-founder and director of the company and chairman of Gopher Asset Management Co., Ltd., has been appointed as the chief executive officer of the company, effective December 29, 2023.
He will succeed Jingbo Wang, who will remain as the chairwoman of the Board and the chairwoman of Noah&#39;s corporate governance and nominating committee.
The separation of the roles, according to the company, is to achieve better corporate governance pursuant to the Corporate Governance Code.
Yin is one of the founders of the company and has been a director since June 2007.
Yin obtained his bachelor&#39;s degree in economics from Shanghai University of Finance and Economics in Shanghai, China, in July 1997 and received his MBA degree from China Europe International Business School in Shanghai, China, in September 2010.
Price Action: NOAH shares closed higher by 1.44% at $13.37 on Thursday.
Photo via Company

Equities

Management

Financial Services Company Noah Splits CEO And Chairperson Roles: Here's Why

Noah Holdings Appoints Zhe Yin As CEO Effective Immediately, Says Jingbo Wang Will Remain As Chairwoman, Company Separated CEO And Chairperson Roles To Improve Corporate Governance

<h4>Key Takeaways:</h4>
<ul>
<li>An equity swap will give a group of Fanhua shareholders 77% of wealth management firm Puyi, and a Puyi shareholder group 50.1% of Fanhua</li>
<li>The deal comes as Puyi struggles with shrinking revenue and ongoing losses</li>
</ul>
By Warren Yang
Wealth manager&nbsp;Puyi Inc.&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/puyi#NASDAQ">PUYI</a>) has pulled off a sort of shotgun marriage that will closely tie its fate &ndash; and ongoing quest for profitability &ndash; with the far larger and profitable insurance broker&nbsp;Fanhua Inc.&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fanh#NASDAQ">FANH</a>).
Under&nbsp;<a href="https://www.globenewswire.com/news-release/2023/12/27/2801279/0/en/Puyi-Announces-Share-Exchange-Transactions-with-Certain-Shareholders-of-Fanhua.html">a deal</a>&nbsp;announced Wednesday, a group of Fanhua shareholders, including CEO Hu Yinan, will swap some of their stock for newly issued Puyi shares at a ratio of two Fanhua shares for each Puyi share they receive. The transaction will give the Fanhua shareholder group about 77% of Puyi, which in turn will hold a 50.1% of Fanhua.
The transaction, which is expected to close this week, will essentially allow Puyi to obtain a majority stake in Fanhua without spending a dime in cash. The Fanhua shareholder group, meanwhile, will maintain its control of Fanhua through its majority ownership of Puyi.
The deal comes less than a week after Fanhua agreed to transfer a 4.46% stake it held in Puyi back to the wealth manager, in exchange for a 10.5 million yuan ($1.5 million) in cash and 15.41% of Fanhua Puyi Fund Sales (Puyi Fund), a distributor of publicly raised funds that is one of Puyi&rsquo;s key businesses.
Fanhua and Puyi co-created Puyi Fund in 2010, and Fanhua later converted its minority stake in the venture to a 4.46% stake of the parent company Puyi&rsquo;s stock ahead of Puyi&rsquo;s 2018 IPO. But that stake has dwindled in value since then as the profit-challenged Puyi&rsquo;s shares lost about a third of their value amid falling revenue in its last three fiscal years.
The latest share-swap deal that effectively ties the two companies closely together looks somewhat curious, since the Fanhua shareholders paid a hefty premium for their new majority Puyi stake. Reflecting that, Puyi&rsquo;s shares jumped 47% on Wednesday, while Fanhua&rsquo;s rose by 1.7%. Puyi shares already commanded an inflated price-to-sales (P/S) ratio of nearly 15 before the announcement, and that figure rose to 22 after the big stock gains. By comparison the larger&nbsp;Noah Holdings&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/noah#NYSE">NOAH</a>), a much bigger player in China&rsquo;s wealth management market, trades at a far more reasonable ratio of 2.
Perhaps Fanhua and Puyi are betting that synergies from their closer ties can lead to greater growth, especially for Puyi, whose revenue totaled just 114 million yuan for its latest fiscal year through June. That&rsquo;s not too unreasonable, given that their businesses are highly complementary since both sell financial products. But Puyi would really need to post some astronomical growth to justify its latest valuation &ndash; a difficult challenge considering its recent record of shrinking revenues and China&rsquo;s slowing economy growth.
Puyi is also quite low on cash, with just 164 million yuan at end of June, as it continued to lose cash from operations. A glaring problem for Puyi is its lack of investment in new growth engines, which is reflected in its nearly debt-free status as it tightly controls its spending. Its cash expenditure for investment more than halved in the fiscal year to June. While such frugality may look commendable and prudent, it also suggests the company lacks big strategic plans for the kind of growth that most investors want.
The latest tie-up may suggest that Fanhua could be preparing to step in and help Puyi jumpstart its growth, perhaps through an asset injection. Such a move could quickly pump up Puyi&rsquo;s revenue to a much higher level, which might justify the company&rsquo;s big valuation despite its unimpressive revenue trends.
<h3>Cost Control</h3>
Puyi&rsquo;s net loss narrowed in its latest fiscal year, thanks to efforts to reduce operating expenses. It cut marketing costs, switching its focus to &ldquo;stimulating the growth of new investments&rdquo; from opening new accounts, CFO Hu Anlin, who left the company late last month, said on Puyi&rsquo;s conference call to review its latest earnings in September. Puyi also divested a subsidiary and closed a number of branches, while cutting some staff.
The extensive cost controls reflect the rough times for China&rsquo;s highly competitive wealth management industry as growing investor gloom over China&rsquo;s economy dampens demand for the kinds of wealth management products that Puyi sells. As Chinese stocks were some of the world&rsquo;s worst performers this year, Puyi&rsquo;s latest annual revenue dropped nearly 40% in the 12 months to June to the 114 million yuan we previously mentioned.
Puyi distributes third-party wealth management products, with affluent and middle-class retail investors as its main target customers. But it&rsquo;s trying to boost its sales to larger, professional institutional investors that are generally more profitable due to their larger size and trading volumes.
The aggregate value of publicly raised funds that Puyi distributed to its financial institutional clients, including banks, insurers, brokerages and trust companies, jumped 266% year-on-year in the 12 months to June. But its overall distributions of such funds actually decreased during that period, suggesting the company lost quite a lot of smaller individual retail clients over that time.
Sales of publicly raised funds through Puyi Fund are Puyi&rsquo;s primary revenue source. The company prioritizes funds backed by public securities with transparent prices, and conducts due diligence on providers of such products. Such caution is increasingly necessary for wealth management companies in China to avoid losses linked to funds backed by murkier assets. Earlier this month, another wealth management services provider,&nbsp;Hywin Holdings&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hyw#NASDAQ">HYW</a>), ran into trouble in that regard after saying&nbsp;<a href="https://thebambooworks.com/hywin-undermined-in-the-shadows-of-chinas-real-estate-slump/">it was unable</a>&nbsp;to provide promised payments for some of its wealth management products presumably linked to assets in China&rsquo;s troubled real estate market.
Despite its apparent caution lately, Puyi has also been trying to diversify its business. It started a family office operation in 2020 to help rich investors set up trust accounts and provide other related services. But such expansion was a small, incremental move that won&rsquo;t provide a big new revenue boost anytime soon.
The latest deal with Fanhua is a different matter, and could make Puyi&rsquo;s stock worth a new look for investors. Fanhua has a far larger revenue base than Puyi and operates profitably, which will provide major new resources for Puyi. For example, the growing alliance could allow Puyi to diversify its product offerings to include insurance, which could become a major new growth engine. Only time will tell where this new marriage will lead, perhaps even to an eventual true merger of the two companies. But for now, at least, there really isn&rsquo;t much to dislike about the deal for Puyi shareholders.
This article is from an external contributor. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.

Asia

FANH

PUYI

Shrinking Wealth Manager Puyi Finds Big Benefactor In Insurance Broker Fanhua

Noah Holdings reports Q2 results

Morgan Stanley analyst Chiyao Huang maintained a Buy rating on Noah Holdings (NOAH – Research Report) today and set a price target of $13.00. Chiya...

Noah Holdings: Strategic Reorganization and Shareholder Value Amplify Buy Rating

Noah Holdings (NOAH) has released an update. Noah Holdings Private Wealth and Asset Management Limited has implemented a US$50 million share repurc...

Noah Holdings Announces $50M Share Buyback Plan

Noah Holdings Limited (NOAH) Q2 2024 Earnings Call Transcript

Warning: NOAH is at high risk of cutting its dividend

Noah Holdings: Q2 Results Miss And New Buyback Plan Draw Attention

DBS analyst Ken Shih has maintained their bullish stance on NOAH stock, giving a Buy rating on August 29. Ken Shih has given his Buy rating due to ...

Buy Rating on Noah Holdings: Strategic Positioning and Undervalued Stock Highlight Investment Appeal

Noah Holdings (NOAH) has released an update. Noah Holdings Private Wealth and Asset Management Limited reported no change in its authorized share c...

Noah Holdings Maintains Capital, Increases Shares

Readers Identify 23 Ideal August Dividend Buys Out Of 36 Picks

68 Graham All Star Value Stocks Show 55 In September Fit To Buy

AGNC

BBAR

BWLP

BXSL

ESEA

FLEX

GRNT

INSW

JFIN

TRMD

VALE

Press Releases

NOAH HOLDINGS LIMITED ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2024

Fintech

Noah Holdings Limited Announces Results of Annual General Meeting and Payment of Final Dividend and Special Dividend

Noah Holdings Limited Announces Changes to its Board of Directors

Noah Holdings Rewards Shareholders with Record RMB 1,018 Million Dividend Payout Under New Shareholder Return Policy

Noah to Report Second Quarter and Half Year 2024 Unaudited Financial Results on August 28, 2024

Comments

Noah Holdings

Noticias

Últimas noticias sobre Noah Holdings (NYSE:NOAH) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL